The purpose of this Funding Opportunity Announcement (FOA) is to solicit UG3/UH3 phased cooperative agreement research applications to plan and implement behavioral and social intervention clinical trials.
Studies appropriate for this announcement include traditional clinical trials meant to
develop and test behavior change interventions meant to prevent or treat dental, oral, or craniofacial conditions, as well as interventions that are used as tools to understand mechanisms of behavior change.
Awards made under this FOA will initially support a milestone-driven planning phase (UG3) for up to 2 years, with possible transition to a clinical trial implementation phase of up to five years (UH3).
Only UG3 projects that have met the scientific milestones and feasibility requirements may transition to the UH3 phase.
The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA.
The UG3 phase for behavioral and social intervention clinical trials will permit both scientific and operational planning activities.
Scientific planning activities include small-scale data collection to assess the feasibility and/or acceptability of a planned behavioral or social intervention and associated study procedures (e.g., acceptability of study content or mode of delivery; feasibility of proposed data collection procedures; preliminary testing of intervention training and fidelity monitoring procedures).
Operational planning activities include, at a minimum, development of:
the final clinical protocol; the intervention manual or equivalent; the data management system and other tools for data and quality management, safety and operational oversight plans; recruitment and retention strategies; and other essential documents such as the Manual of Procedures for the subsequent clinical trial in the UH3 phase.
The UH3 phase of the award will support the conduct of investigator-initiated intervention research at all stages, from early mech